27457339|t|Investigating Effects of Acidic pH on Proliferation, Invasion and Drug - Induced Apoptosis in Lymphoblastic Leukemia
27457339|a|Some studies have shown that extracellular pH in tumors, which results in tumor progression, is less than that in normal tissues. The aim of this study was to investigate the effects of extracellular acidic pH on proliferation, invasion, and drug - induced apoptosis in acute lymphoblastic cells. The cells were cultured in different pH (pH 6.6 and pH 7.4) for 12 days. Cell proliferation was assessed by MTT assay and cell invasion was assayed by invasion assay and gene expression analysis of MMP-9. Drug - induced apoptosis was evaluated after exposure to doxorubicin for 24 hours by annexin V / PI staining and gene expression analysis of BAX pro-apoptotic protein. The results indicated the enhanced growth and invasion of leukemic cells at pH 6.6 (P ≤ 0.05). Furthermore, the cells at pH 6.6 were resistant to apoptosis by doxorubicin (P ≤ 0.05). It can be concluded that acidic pH increases the proliferation, invasion and reduces the drug - induced apoptosis in acute lymphoblastic leukemia. Extracellular acidity can influence the behavior of leukemic cells and therefore, the manipulation of extracellular liquid can be selected as a therapeutic strategy for leukemia, especially for acute lymphoblastic leukemia.
27457339	38	51	Proliferation	T038	UMLS:C0596290
27457339	53	61	Invasion	T038	UMLS:C2699153
27457339	66	70	Drug	T103	UMLS:C1254351
27457339	81	90	Apoptosis	T038	UMLS:C0162638
27457339	94	116	Lymphoblastic Leukemia	T038	UMLS:C0023448
27457339	146	159	extracellular	T082	UMLS:C0015352
27457339	166	172	tumors	T038	UMLS:C0027651
27457339	191	208	tumor progression	T038	UMLS:C0178874
27457339	238	245	tissues	T017	UMLS:C0040300
27457339	263	268	study	T062	UMLS:C2603343
27457339	303	316	extracellular	T082	UMLS:C0015352
27457339	330	343	proliferation	T038	UMLS:C0596290
27457339	345	353	invasion	T038	UMLS:C2699153
27457339	359	363	drug	T103	UMLS:C1254351
27457339	374	383	apoptosis	T038	UMLS:C0162638
27457339	387	412	acute lymphoblastic cells	T017	UMLS:C0883208
27457339	418	423	cells	T017	UMLS:C0883208
27457339	487	505	Cell proliferation	T038	UMLS:C0596290
27457339	522	531	MTT assay	T062	UMLS:C2986858
27457339	536	549	cell invasion	T038	UMLS:C2699153
27457339	565	579	invasion assay	T058	UMLS:C0022885
27457339	584	608	gene expression analysis	T062	UMLS:C1880945
27457339	612	617	MMP-9	T103	UMLS:C0165519
27457339	619	623	Drug	T103	UMLS:C1254351
27457339	634	643	apoptosis	T038	UMLS:C0162638
27457339	676	687	doxorubicin	T103	UMLS:C0013089
27457339	704	713	annexin V	T103	UMLS:C0059249
27457339	716	718	PI	T103	UMLS:C0033470
27457339	719	727	staining	T058	UMLS:C0487602
27457339	732	756	gene expression analysis	T062	UMLS:C1880945
27457339	760	785	BAX pro-apoptotic protein	T103	UMLS:C0219474
27457339	822	828	growth	T038	UMLS:C0007595
27457339	833	841	invasion	T038	UMLS:C2699153
27457339	845	853	leukemic	T038	UMLS:C0023418
27457339	854	859	cells	T017	UMLS:C0007634
27457339	899	904	cells	T017	UMLS:C0007634
27457339	933	942	apoptosis	T038	UMLS:C0162638
27457339	946	957	doxorubicin	T103	UMLS:C0013089
27457339	1019	1032	proliferation	T038	UMLS:C0596290
27457339	1034	1042	invasion	T038	UMLS:C2699153
27457339	1059	1063	drug	T103	UMLS:C1254351
27457339	1074	1083	apoptosis	T038	UMLS:C0162638
27457339	1087	1115	acute lymphoblastic leukemia	T038	UMLS:C0023449
27457339	1117	1130	Extracellular	T082	UMLS:C0015352
27457339	1169	1177	leukemic	T038	UMLS:C0023418
27457339	1178	1183	cells	T017	UMLS:C0007634
27457339	1219	1239	extracellular liquid	T031	UMLS:C0015349
27457339	1261	1281	therapeutic strategy	T058	UMLS:C0087111
27457339	1286	1294	leukemia	T038	UMLS:C0023418
27457339	1311	1339	acute lymphoblastic leukemia	T038	UMLS:C0023449